RNA

Irafasha C Casmil1, Jongwoo Jin2, Eun-Jeong Won3

  • 1Michael Smith Laboratories, University of British Columbia, Vancouver, BC V6T1Z4, Canada; School of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T1Z3, Canada.

概括

与mRNA疫苗相比,自我放大RNA (saRNA) 疫苗提供了增强的免疫性和成本效益. 本综述探讨了saRNA在传染病方面的进展,强调了它对未来免疫策略的潜力.